Back to search

Article

Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer

2025-10-15

Abstract excerpt

Thyroid cancer is the most common endocrine malignancy, particularly in patients with radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC), who have limited treatment options and poor clinical prognosis. In this study, doxorubicin (DOX) and sorafenib (SOR) were loaded into the photothermal conversion agent mesoporous polydopamine (mPDA), forming mPDS. Tumor cell membrane coating engineering resul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
391713b2-8311-565b-ba8e-96a38ba44ca2
DOI
10.1101/2025.10.15.682623
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid CancerDOI 10.1101/2025.10.15.682623
Select a neighboring publication to make it the new centre.